Detailed answers about HEALTH & VISION LIMITED, including incorporation, status, business activity, and accounts information.
When was HEALTH & VISION LIMITED founded?
HEALTH & VISION LIMITED was officially incorporated on 21 October 2010 and is registered under company number 07414960. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is HEALTH & VISION LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of HEALTH & VISION LIMITED?
HEALTH & VISION LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does HEALTH & VISION LIMITED do?
HEALTH & VISION LIMITED operates in the following sector: 82990 - Other business support service activities n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is HEALTH & VISION LIMITED's registered address?
The registered office address of HEALTH & VISION LIMITED is 15 RIDING CLOSE, SALE, CHESHIRE, M33 2ZP. This is the official address filed with Companies House for legal and statutory correspondence.
Is HEALTH & VISION LIMITED financially stable?
The most recent accounts for HEALTH & VISION LIMITED were made up to 31 October 2024, filed as MICRO ENTITY. Next accounts are due by 31 July 2026.
Does HEALTH & VISION LIMITED have any charges or mortgages?
HEALTH & VISION LIMITED has 1 registered charge, of which 1 is outstanding, 0 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.